RCT Comparing Intravaginal Laser Therapy to Sham in Post-menopausal Women with Recurrent Urinary Tract Infections

NAActive, not recruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

October 8, 2026

Study Completion Date

October 8, 2026

Conditions
Recurrent Urinary Tract InfectionGenitourinary Syndrome of Menopause
Interventions
DEVICE

Deka SmartXide Touch C60 (MonaLisa Touch)

Intravaginal micro-ablative fractional CO2 laser technology Deka SmartXide Touch C60 (MonaLisa Touch)

DEVICE

Sham

Participants receiving sham treatment will have the probes advanced in the same manner without the use of a laser energy device.

Trial Locations (1)

SE5 9RS

King's College Hospital, London

All Listed Sponsors
lead

King's College Hospital NHS Trust

OTHER

NCT06124820 - RCT Comparing Intravaginal Laser Therapy to Sham in Post-menopausal Women with Recurrent Urinary Tract Infections | Biotech Hunter | Biotech Hunter